$930 million sale of Blue Bell biopharma firm finalized
January 29, 2020 at 14:04 PM EST
The purchase price could grow if the Food and Drug Administration approves an experimental therapy that combines a product from each company.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|